BALCHEM CORP
For the period ended Dec 31, 2025. Filed Feb 20, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 20, 2026
BCPC$173.54-1.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets as of December 31, 20 and
Consolidated Balance Sheets
December 31, 2025 and 2024
(Dollars in thousands, except share and per share data)
| 2025 | 2024 | |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $74,570 | $49,515 |
| Accounts receivable, net of allowance for credit losses of $862 and $909 at December 31, 2025 and 2024, respectively | 143,596 | 119,662 |
| Inventories, net | 131,449 | 130,802 |
| Prepaid expenses | 9,778 | 8,054 |
| Other current assets | 6,221 | 5,737 |
| Total current assets | 365,614 | 313,770 |
| Property, plant and equipment, net | 306,648 | 282,154 |
| Goodwill | 816,375 | 780,030 |
| Customer relationships and lists | 132,994 | 132,484 |
| Other intangible assets with finite lives, net | 30,295 | 32,566 |
| Right of use assets - operating leases | 14,672 | 15,320 |
| Right of use assets - finance lease | 1,520 | 1,730 |
| Other non-current assets | 18,134 | 17,317 |
| Total assets | $1,686,252 | $1,575,371 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Trade accounts payable | $60,425 | $54,745 |
| Accrued expenses | 49,288 | 43,750 |
| Accrued compensation and other benefits | 27,896 | 22,886 |
| Dividends payable | 31,044 | 28,510 |
| Income tax payable | 3,912 | 4,466 |
| Operating lease liabilities - current | 3,614 | 3,134 |
| Finance lease liabilities - current | 205 | 194 |
| Total current liabilities | 176,384 | 157,685 |
| Revolving loan | 164,000 | 190,000 |
| Deferred income taxes | 54,143 | 43,722 |
| Operating lease liabilities - non-current | 11,324 | 12,967 |
| Finance lease liabilities - non-current | 1,544 | 1,749 |
| Other long-term obligations | 21,444 | 19,335 |
| Total liabilities | 428,839 | 425,458 |
| Commitments and contingencies (Note 15) | ||
| Stockholders’ equity: | ||
| Preferred stock, $25 par value. Authorized 2,000,000 shares; none issued and outstanding | — | — |
| Common stock, $.0667 par value. Authorized 120,000,000 shares; 32,058,121 shares issued and outstanding at December 31, 2025 and 32,527,244 shares issued and outstanding at December 31, 2024, respectively | 2,139 | 2,170 |
| Additional paid-in capital | 92,331 | 173,997 |
| Retained earnings | 1,121,396 | 997,493 |
| Accumulated other comprehensive income (loss) | 41,547 | (23,747) |
| Total stockholders’ equity | 1,257,413 | 1,149,913 |
| Total liabilities and stockholders’ equity | $1,686,252 | $1,575,371 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.